Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ·Healthcare·Biotechnology
$2.37
-0.63%
Mkt Cap $261.81M
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (15 analysts)
$5.32
Range $2.95 – $9.00
Implied Upside
+124.5%
Consensus $5.32 vs current $2.37
NASDAQ·Healthcare·Biotechnology
$2.37
-0.63%
Mkt Cap $261.81M
Buy
7
Hold
1
Sell
0
Price Target (15 analysts)
$5.32
Range $2.95 – $9.00
+124.5%
Consensus $5.32 vs current $2.37